Citius Pharmaceuticals, INC. (CTXR) SEC Filings — 2024
29 SEC filings for Citius Pharmaceuticals, INC. (CTXR) in 2024.
Filings
- Citius Pharmaceuticals Files 8-K on Financials — 8-K · Dec 27, 2024
- Citius Pharma Sells Mino-Lok to NovaBay for $10M Upfront — 8-K · Dec 20, 2024
- Mazur Amends Citius Pharma 13D Filing — SC 13D/A · Nov 27, 2024
- Citius Pharmaceuticals Files 8-K on Security Holder Rights — 8-K · Nov 26, 2024
- Citius Pharmaceuticals Files 8-K — 8-K · Nov 25, 2024
- Citius Pharmaceuticals Files 8-K: Material Agreement Announced — 8-K · Nov 18, 2024
- Citius Pharma Faces Nasdaq Delisting Risk — 8-K · Nov 13, 2024
- Citius Pharmaceuticals Files 8-K — 8-K · Nov 12, 2024
- Citius Pharma Enters Material Definitive Agreement — 8-K · Sep 27, 2024
- Citius Pharmaceuticals Enters Material Definitive Agreement — 8-K · Sep 13, 2024
- Citius Pharma Faces Nasdaq Delisting Warning — 8-K · Sep 11, 2024
- Citius Pharmaceuticals Files 8-K — 8-K · Sep 5, 2024
- Citius Pharma Secures Loan Agreement with Innoviva — 8-K · Aug 16, 2024
- Citius Pharmaceuticals Files Q2 2024 10-Q Report — 10-Q · Aug 12, 2024
- Citius Pharmaceuticals Files 8-K — 8-K · Aug 8, 2024
- Citius Pharmaceuticals Files 8-K — 8-K · May 21, 2024
- Citius Pharmaceuticals, Inc. Files Quarterly Report (10-Q) for Period Ended March 31, 2024 — 10-Q · May 14, 2024
- Citius Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · May 8, 2024
- Citius Pharmaceuticals Files 8-K, Enters Material Agreement — 8-K · Apr 30, 2024
- Citius Pharma to Acquire NovaLead Pharma for $15M — 8-K · Apr 5, 2024
- Citius Pharmaceuticals Files 8-K — 8-K · Mar 18, 2024
- Citius Pharmaceuticals Faces Delisting Concerns — 8-K · Mar 13, 2024
- Citius Pharma Files 8-K on Financial Condition and Operations — 8-K · Feb 15, 2024
- Citius Pharmaceuticals, Inc. Files 10-Q for Period Ended December 31, 2023 — 10-Q · Feb 14, 2024
- BlackRock Discloses 5.0% Stake in Citius Pharmaceuticals — SC 13G · Jan 31, 2024
- Citius Pharma Files Definitive Additional Proxy Materials — DEFA14A · Jan 26, 2024
- Citius Pharma Files 8-K on 'Other Events' & Financial Exhibits — 8-K · Jan 23, 2024
- Citius Pharma Adopts Shareholder Proxy Access for Director Nominations — 8-K · Jan 5, 2024
- Citius Pharma Files 8-K, Confirms Nasdaq Listing for CTXR — 8-K · Jan 2, 2024